Calcific Aortic Valve Stenosis: A Focal Disease in Older and Complex Patients-What Could Be the Best Time for an

Annamaria Mazzone1, Augusto Esposito1, Ilenia Foffa1,2

  • 1Fondazione Toscana Gabriele Monasterio Massa, 54100 Massa, Italy.

PubMed

Insights

Calcific aortic stenosis (CAS) management in the elderly is complex. This review integrates aging factors and biomarkers to determine optimal timing for interventions like aortic valve replacement (AVR).

Area of Science:

  • Cardiology
  • Geriatrics
  • Biomarker Research

Background:

  • Calcific aortic stenosis (CAS) is a growing concern in aging populations worldwide.
  • Decisions regarding aortic valve replacement (SAVR, TAVR) for severe CAS in elderly patients are complex, balancing risks and benefits.
  • CAS in older adults involves multifaceted factors beyond valve disease, including aging, frailty, and comorbidities.

Purpose of the Study:

  • To analyze the natural history and progression of aortic stenosis in the elderly.
  • To explore phenotypes of myocardial damage and heart failure in aging patients with CAS.
  • To propose optimal timing for interventional treatment of CAS in older individuals using integrated biomarkers.

Main Methods:

  • Review of natural and prognostic histories of aortic stenosis progression.
  • Analysis of myocardial damage and heart failure phenotypes in aging.
  • Integration of clinical, geriatric, chemical, and advanced imaging biomarkers.

Main Results:

  • CAS in the elderly presents significant phenotypic heterogeneity and complex aging trajectories.
  • Subjective symptoms alone are insufficient for determining optimal intervention timing.
  • A comprehensive biomarker approach is crucial for personalized treatment decisions.

Conclusions:

  • Optimal interventional timing for CAS in elderly patients requires integrating multiple data sources.
  • Biomarker-driven strategies can improve outcomes beyond symptom-based assessments.
  • Personalized management is key to avoiding adverse events and improving quality of life in older adults with CAS.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
43
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
26
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
30
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
55
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
36